RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Maria C. Tamargo to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Maria C. Tamargo has written about Angiotensin-Converting Enzyme Inhibitors.
Maria C. Tamargo
Connection Strength
0.784
Angiotensin-Converting Enzyme Inhibitors
  1. Tamargo M, Tamargo J. New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors. Eur Heart J Cardiovasc Pharmacother. 2018 10 01; 4(4):193-194.
    View in: PubMed
    Score: 0.639
  2. Tamargo M, Tamargo J. Future drug discovery in renin-angiotensin-aldosterone system intervention. Expert Opin Drug Discov. 2017 08; 12(8):827-848.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support